Showing results (321-330 of 376) with videos related to

Sort By:
Pageof 38
JAMA|February 15, 2001
Risk of new vertebral fracture in the year following a fractureR Lindsay, S L Silverman, C Cooper, et al.
Injury|September 24, 2011
Impact of guideline implementation by a fracture nurse on subsequent fractures and mortality in patients presenting with non-vertebral fracturesKirsten M B Huntjens, Tineke C M van Geel, Piet P Geusens, et al.
BMC Musculoskeletal Disorders|April 6, 2013
The role of the combination of bone and fall related risk factors on short-term subsequent fracture risk and mortalityKirsten M B Huntjens, Tineke A C M van Geel, Svenhjalmar van Helden, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2001
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaquesC R Dhore, J P Cleutjens, E Lutgens, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 23, 2017
Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosisO A Oshagbemi, J H M Driessen, A Pieffers, et al.
The New England Journal of Medicine|November 30, 1995
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study GroupU A Liberman, S R Weiss, J Bröll, et al.
Annals of the Rheumatic Diseases|July 4, 2006
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hipF P Luyten, P Geusens, M Malaise, et al.
Maturitas|July 12, 2011
Vertebral fractures in women aged 50 years and older with clinical risk factors for fractures in primary careMartha van den Berg, Noortje A Verdijk, Joop P W van den Bergh, et al.
The New England Journal of Medicine|February 15, 2001
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study GroupM R McClung, P Geusens, P D Miller, et al.
Nature Clinical Practice. Rheumatology|April 10, 2008
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspectivePiet P Geusens, Christian H Roux, David M Reid, et al.
Pageof 38